Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Prostate Cancer

Free Subscription 17.06.2024 2 AJR Am J Roentgenol 2 BMC Cancer 1 Cancer 2 Cancer Res 1 Eur Radiol 1 Eur Urol 2 Int J Radiat Oncol Biol Phys 1 J Clin Oncol 1 J Nucl Med 5 J Urol 1 JAMA 1 Oncogene 1 PLoS One 1 Radiol Artif Intell 1 Radiology 1 Urology

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

AJR Am J Roentgenol

1. DE OLIVEIRA CORREIA ET, Purysko AS, Paranhos BM, Shoag JE, et al
   Reply to "Is PI-RADS Ready for Biparametric Prostate MRI?".
   AJR Am J Roentgenol. 2024 Mar 20. doi: 10.2214/AJR.24.31169.
   PubMed        
   
   
2. DANA J, Reinhold C, Gauvin S
   Is PI-RADS Ready for Biparametric Prostate MRI?
   AJR Am J Roentgenol. 2024 Mar 20. doi: 10.2214/AJR.24.31094.
   PubMed        
   
   

   
   BMC Cancer

3. ZHU Q, Chen J, Liu H, Zhao J, et al
   The efficacy and safety of PARP inhibitors in mCRPC with HRR mutation in second-line treatment: a systematic review and bayesian network meta-analysis.
   BMC Cancer. 2024;24:706.
   PubMed         Abstract available
   
   
4. XU X, Wang W, He Y, Yao Y, et al
   Prognostic marker VPS72 could promote the malignant progression of prostate cancer.
   BMC Cancer. 2024;24:713.
   PubMed         Abstract available
   
   

   
   Cancer

5. PAGADALA MS, Lui A, Lynch J, Karunamuni R, et al
   Healthy lifestyle and prostate cancer risk in the Million Veteran Program.
   Cancer. 2024 Jun 12. doi: 10.1002/cncr.35434.
   PubMed         Abstract available
   
   

   
   Cancer Res

6. LI W, Guo F, Zeng R, Liang H, et al
   CDK4/6 Alters TBK1 Phosphorylation to Inhibit the STING Signaling Pathway in Prostate Cancer.
   Cancer Res. 2024 Jun 11. doi: 10.1158/0008-5472.CAN-23-3704.
   PubMed         Abstract available
   
   
7. ZHANG W, Maeser D, Lee A, Huang Y, et al
   Integration of Pan-Cancer Cell Line and Single-Cell Transcriptomic Profiles Enables Inference of Therapeutic Vulnerabilities in Heterogeneous Tumors.
   Cancer Res. 2024;84:2021-2033.
   PubMed         Abstract available
   
   

   
   Eur Radiol

8. PONSIGLIONE A, Gambardella M, Stanzione A, Green R, et al
   Radiomics for the identification of extraprostatic extension with prostate MRI: a systematic review and meta-analysis.
   Eur Radiol. 2024;34:3981-3991.
   PubMed         Abstract available
   
   

   
   Eur Urol

9. ADELEKE S
   High-performing, Accessible, and Affordable Imaging in Metastatic Prostate Cancer: Is Whole-body Magnetic Resonance Imaging the Answer?
   Eur Urol. 2024 Jun 12:S0302-2838(24)02410-2. doi: 10.1016/j.eururo.2024.
   PubMed        
   
   

   
   Int J Radiat Oncol Biol Phys

10. NIKITAS J, Ong WL, Carrier N, Romero T, et al
    Prostate-Specific Antigen Response to Androgen Deprivation Therapy in the Neoadjuvant Setting for High-Risk Prostate Adenocarcinoma (PIRANHA): Pooled Analysis of Two Randomized Clinical Trials.
    Int J Radiat Oncol Biol Phys. 2024;119:826-831.
    PubMed         Abstract available
    
    
11. ONG WL, Nikitas J, Joseph D, Steigler A, et al
    Long-Term Quality-of-Life Outcomes After Prostate Radiation Therapy With or Without High-Dose-Rate Brachytherapy Boost: Post Hoc Analysis of TROG 03.04 RADAR.
    Int J Radiat Oncol Biol Phys. 2024;119:813-825.
    PubMed         Abstract available
    
    

    
    J Clin Oncol

12. GARCIA JA, Spratt DE
    Is It Premature to Accept Radiographic Progression-Free Survival as a Surrogate End Point in Metastatic Hormone-Sensitive Prostate Cancer?
    J Clin Oncol. 2024 Jun 14:JCO2400210. doi: 10.1200/JCO.24.00210.
    PubMed        
    
    

    
    J Nucl Med

13. KUO PH, Esposito G, Ulaner GA, Yoo D, et al
    Interreader and Intrareader Reproducibility of (18)F-Flotufolastat Image Interpretation in Patients with Newly Diagnosed or Recurrent Prostate Cancer: Data from Two Phase 3 Prospective Multicenter Studies.
    J Nucl Med. 2024 Jun 13:jnumed.123.267306. doi: 10.2967/jnumed.123.267306.
    PubMed         Abstract available
    
    

    
    J Urol

14. TILL C, Goodman PJ, Tangen C, Lucia MS, et al
    Letter: Survival After Selenium and Vitamin E Supplementation: Long-Term Followup of the Selenium and Vitamin E Cancer Prevention Trial.
    J Urol. 2024;212:228-229.
    PubMed        
    
    
15. NAHAS WC, Rodrigues GJ, Rodrigues Goncalves FA, Sawczyn GV, et al
    Perioperative, Oncological, and Functional Outcomes Between Robot-Assisted Laparoscopic Prostatectomy and Open Radical Retropubic Prostatectomy: A Randomized Clinical Trial.
    J Urol. 2024;212:32-40.
    PubMed         Abstract available
    
    
16. MIAN BM, Bernstein A, Kaufman RP Jr, Fisher HAG, et al
    Reply: Complications Following Transrectal and Transperineal Prostate Biopsy: Results of the ProBE-PC Randomized Clinical Trial.
    J Urol. 2024;212:227-228.
    PubMed        
    
    
17. MOTA SM, Priester A, Shubert J, Bong J, et al
    Artificial Intelligence Improves the Ability of Physicians to Identify Prostate Cancer Extent.
    J Urol. 2024;212:52-62.
    PubMed         Abstract available
    
    
18. LEWICKI P, Morgan T
    The Genomics and Natural History of MRI Visible vs. Invisible Prostate Cancer: Clinical Implications".
    J Urol. 2024 Jun 12:101097JU0000000000004104. doi: 10.1097/JU.0000000000004104.
    PubMed        
    
    

    
    JAMA

19. FENG X, Zahed H, Onwuka J, Callister MEJ, et al
    Cancer Stage Compared With Mortality as End Points in Randomized Clinical Trials of Cancer Screening: A Systematic Review and Meta-Analysis.
    JAMA. 2024;331:1910-1917.
    PubMed         Abstract available
    
    

    
    Oncogene

20. FRANCIS JC, Capper A, Rust AG, Ferro K, et al
    Identification of genes that promote PI3K pathway activation and prostate tumour formation.
    Oncogene. 2024;43:1824-1835.
    PubMed         Abstract available
    
    

    
    PLoS One

21. YAMADA Y, Urabe F, Kimura S, Iwatani K, et al
    The prognostic significance of additional localized treatment to primary lesion in patients undergoing hormone therapy for metastatic hormone-sensitive prostate cancer: A systematic review and meta-analysis.
    PLoS One. 2024;19:e0304963.
    PubMed         Abstract available
    
    

    
    Radiol Artif Intell

22. FASSIA MK, Balasubramanian A, Woo S, Vargas HA, et al
    Deep Learning Prostate MRI Segmentation Accuracy and Robustness: A Systematic Review.
    Radiol Artif Intell. 2024 Apr 3:e230138. doi: 10.1148/ryai.230138.
    PubMed         Abstract available
    
    

    
    Radiology

23. SCHIEDA N, Nisha Y, Hadziomerovic AR, Prabhakar S, et al
    Comparison of Positive Predictive Values of Biparametric MRI and Multiparametric MRI-directed Transrectal US-guided Targeted Prostate Biopsy.
    Radiology. 2024;311:e231383.
    PubMed         Abstract available
    
    

    
    Urology

24. STANIORSKI CJ, Malek MM, Waltz PK, Reyes-Mugica M, et al
    Pelvic Neuroblastoma of the Pediatric Prostate.
    Urology. 2024;187:82-85.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Prostate Cancer is free of charge.